Therapeutics Ocumension

Affiliations

  • Director at Eyepoint Pharmaceuticals Inc. (EYEP), 2024-01-16
  • Large Shareholder at Alimera Sciences Inc (ALIM), 2021-04-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EYEP $19.45 1,910,500 Director 100,221 2024-01-11 Filing
EYEP $18.41 266,242 Director 2,010,721 2023-12-06 Filing
EYEP $19.91 733,758 Director 2,276,963 2023-12-05 Filing